drugset / Trial / NCT05600322
Comparative Study of Hexvix Blue Light Cystoscopy and White Light Cystoscopy in the Detection of Bladder Cancer
Phase 3
Completed
158 enrolled
Photocure
Jiangsu Yahong Meditech Co., Ltd aka Asieris · collabRichard Wolf GmbH · collabTigermed-Jyton Co., Ltd. · collab
NaSingle-groupOpen-labelDiagnostic
Summary
A study to compare Hexvix Blue light cstoscopy with standard White light cystoscopy in the detection of bladder cancer.
Timeline
- Start
- 2022-11-03
- Primary completion
- 2023-07-12
- Completion
- 2023-07-12
Outcome
Met primary endpoint
release “Hexvix ® Phase III bridging trial in China has successfully met its primary research endpoint.” photocure.com ↗
release “blue light cystoscopy improves bladder cancer detection in comparison to white light cystoscopy: a prospective, comparative, within-patient controlled multicenter phase III bridging study” photocure.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | hexaminolevulinate | Small molecule | 50 ml | Intravenous |